Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.902
0.00 (0.00%)
Jul 17, 2026, 5:35 PM CET
Oryzon Genomics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Oryzon Genomics stock has a consensus rating of "Strong Buy" and an average price target of €7.13. The average 1-year stock price forecast is 145.69% higher than the current stock price, while the lowest is €4.20 (+44.73%) and the highest is €12.00 (+313.51%).
Price Target: €7.13 (+145.69%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 12, 2026.
Analyst Ratings
The average analyst rating for Oryzon Genomics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains €8.74 | Buy | Maintains | €8.74 | +201.14% | Jun 12, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains €4.20 | Buy | Maintains | €4.20 | +44.73% | May 25, 2026 |
Financial Forecast
Revenue This Year
7.50M
from 12.84M
Decreased by -41.60%
Revenue Next Year
19.32M
from 7.50M
Increased by 157.62%
EPS This Year
-0.12
from -0.04
EPS Next Year
0.01
from -0.12
EPS and Forward PE are based on non-GAAP adjusted numbers.